What is driving ALNA stock volume today?

ALNA stock volume is driven by speculative trading and headline sensitivity typical for small biotech names. Heavy pre-market flow of **252,311,606** shares suggests block trades and retail interest rather than immediate fundamental change.

How does Allena’s balance sheet affect ALNA stock outlook?

Allena reports cash per share **$0.92** and a current ratio **2.11**, which suggests short-term liquidity. These metrics reduce immediate bankruptcy risk but do not remove clinical or funding execution risk for ALNA stock.

What price targets does Meyka AI show for ALNA stock?

Meyka AI's forecast model projects a 12-month base case **$0.12**, bull **$0.30**, and bear **$0.03**, implying +60.00%, +300.00%, and -60.00% from the current **$0.075**. Forecasts are projections, not guarantees.

Should investors buy ALNA stock now?

ALNA stock is high-volatility and speculative. Meyka AI assigns a **B** grade and a HOLD suggestion based on mixed fundamentals and sector factors. Investors should do due diligence and size positions for risk.

US Stocks

ALNA Allena Pharma NASDAQ Pre-Mkt 06 Feb 2026: Vol 252.31M watch catalyst

ByDanny Kontos February 6, 2026February 6, 2026

ALNA stock is trading in the pre-market on 06 Feb 2026 at $0.075 with heavy turnover, 252,311,606 shares reported. Allena Pharmaceuticals, Inc. (ALNA) on the NASDAQ is drawing volume as traders react to microcap biotech positioning and pipeline updates. We look at price action, key ratios like EPS -0.638 and PB 0.13, and the trading risks that make ALNA stock a high-volatility, speculative idea in the United States (USD).